Biolinerx (BLRX) Reports Q3 Loss of NIS 0.15
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
Biolinerx (NASDAQ: BLRX) reported Q3 EPS of NIS (0.15), versus NIS (0.06) reported last year.
For earnings history and earnings-related data on Biolinerx (BLRX) click here.
For earnings history and earnings-related data on Biolinerx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Outlook Therapeutics posts Q3 loss, eyes U.S. LYTENAVA launch by end of 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
